Conciseness

The body is dense and tool-specific with almost no filler — API-key requirements, fallbacks, exact parameter values, and known upstream failures (the EnsemblPheno HTTP 500 note) all earn their tokens. A few sections could be trimmed, e.g., the multi-sentence G2P/GenCC concordance commentary and parts of the evidence-hierarchy paragraph restate domain knowledge Claude already has, so it sits at 'efficient; minor instances of over-explanation' rather than the lean score-5 anchor.

Actionability

Fully executable, copy-paste-ready guidance: complete initialization (`from tooluniverse import ToolUniverse; tu.load_tools()`), exact tool names with real parameters (`DisGeNET_get_gda(gene=..., source="CURATED", min_score=0.3, limit=25)`), concrete output consumption (`g2p_hits["data"]["results"][0]["stable_id"]`), an example synthesis table, and specific troubleshooting fixes. This matches the score-5 anchor of copy-paste-ready code covering the common cases.

Workflow Clarity

The 7-phase workflow is clearly sequenced with an ASCII overview, entry-point alternatives (gene vs disease query), input dependencies noted ('Both require pre-resolved Ensembl/EFO IDs'), and a thorough Troubleshooting section giving error→fix feedback loops for each tool. It falls short of the score-5 anchor because validation checkpoints (verify IDs resolved, confirm non-empty results before synthesis) live in Troubleshooting rather than as explicit inline checkpoints in the phase sequence.

Progressive Disclosure

No references/, scripts/, or assets/ directories exist, and the single ~250-line SKILL.md inlines roughly 150 lines of per-tool API reference (all seven phases' call signatures, G2P/GenCC/Orphanet details, troubleshooting entries) that clearly belongs in separate reference files — mirroring the score-3 anchor of well-structured content with inline material that should be split out. Section organization itself is good, which keeps it above score 2.

Specificity

The description lists multiple concrete actions — 'association analysis across' seven named databases, 'cross-references multiple sources for evidence-graded association reports', 'concordance scoring (5/5 sources agree → strong, 1/5 → weak)', and 'clinical-panel-based curation' with named panels — covering the domain comprehensively. It is not merely the score-4 anchor because the coverage of actions (query, cross-reference, score, curate by panel) is complete rather than having minor gaps.

Completeness

Explicitly answers 'what' ('gene-disease association analysis across [databases]... evidence-graded association reports with concordance scoring') and 'when' with a concrete 'Use for...' clause quoting two literal trigger phrases. This matches the score-5 anchor: both what and when are clearly and explicitly stated with concrete trigger phrases.

Trigger Term Quality

Includes natural query phrasings users would actually say ('which diseases is gene X associated with', 'which genes cause disease Y') plus the seven database names and panel terms — good keyword coverage. It falls short of the score-5 anchor because common synonyms like 'linked to', 'risk gene', or 'disease-causing gene' are absent.

Distinctiveness Conflict Risk

The niche is well-defined (multi-database gene-disease association scoring) with distinctive terms (concordance scoring, clinical panels, named databases), giving minimal generic conflict risk. However, sibling skills exist (e.g., tooluniverse-rare-disease-diagnosis, tooluniverse-disease-research referenced in the body), and the 'which genes cause disease Y' trigger overlaps with them — mostly distinct with minor overlap risk, matching the score-4 anchor.